These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 2337488)
1. [Nervous disease & Ca antagonist]. Otomo E No To Shinkei; 1990 Jan; 42(1):33-41. PubMed ID: 2337488 [No Abstract] [Full Text] [Related]
2. [Calcium channel blockers in therapy of neurologic diseases]. Wessely P; Wöber-Bingöl C Wien Med Wochenschr; 1993; 143(19-20):514-8. PubMed ID: 8135034 [TBL] [Abstract][Full Text] [Related]
3. [Ca antagonists in neurosurgical practice]. Handa J; Shiino A; Kidooka M No To Shinkei; 1990 Jan; 42(1):43-52. PubMed ID: 2186764 [No Abstract] [Full Text] [Related]
5. [The treatment of migraine]. Titus F Rev Neurol; 1997 Feb; 25(138):295-300. PubMed ID: 9147762 [No Abstract] [Full Text] [Related]
6. Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders. Jansen I; Tfelt-Hansen P; Edvinsson L Eur J Clin Pharmacol; 1991; 40(1):7-15. PubMed ID: 2060549 [TBL] [Abstract][Full Text] [Related]
7. [The usage of calcium channel blockers in acute cerebral ischemia]. Ara JR; Errea JM; Calderón C; Marzo ME; Serrano C; Hermida I Rev Neurol; 1995; 23(120):450. PubMed ID: 7497207 [No Abstract] [Full Text] [Related]
8. Is there a common pharmacological link between migraine and epilepsy? Wauquier A Funct Neurol; 1986; 1(4):515-20. PubMed ID: 3301559 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up after flunarizine or nimodipine discontinuation in migraine patients. Nuti A; Lucetti C; Pavese N; Dell'Agnello G; Rossi G; Bonuccelli U Cephalalgia; 1996 Aug; 16(5):337-40. PubMed ID: 8869769 [TBL] [Abstract][Full Text] [Related]
10. Use of calcium channel blockers in acute ischemic cerebrovascular disease. Sood AK; Dua A; Mahajan A; Arora S J Assoc Physicians India; 1996 Jan; 44(1):70. PubMed ID: 8773106 [No Abstract] [Full Text] [Related]
11. [Calcium channel blockers in preventive treatment of migraine]. Rødahl E Tidsskr Nor Laegeforen; 1988 Sep; 108(25):2040-2. PubMed ID: 3059559 [No Abstract] [Full Text] [Related]
12. Efficacy of Nimodipine Plus Yufeng Ningxin Tablets for Patients with Frequent Migraine. Mu H; Wang L Pharmacology; 2018; 102(1-2):53-57. PubMed ID: 29879719 [TBL] [Abstract][Full Text] [Related]
13. Is there a need for alternative approaches in the therapy of cerebrovascular disorders? Hartmann A Eur Neurol; 1986; 25 Suppl 1():7-26. PubMed ID: 3758110 [TBL] [Abstract][Full Text] [Related]
14. [The effects of nimodipine on cerebrovascular function in acute cerebral infarction]. Long J; Wang G; Bai Y Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):679-81. PubMed ID: 11038793 [TBL] [Abstract][Full Text] [Related]
15. [Mechanism of action of calcium antagonists in the treatment of vascular diseases]. Mayerhofer S Wien Med Wochenschr; 1986 Nov; 136(21-22):591-4. PubMed ID: 2435066 [TBL] [Abstract][Full Text] [Related]
16. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025 [TBL] [Abstract][Full Text] [Related]
17. Calcium antagonists in migraine and vertigo. Possible mechanisms of action and review of clinical trials. Olesen J Eur Neurol; 1990; 30 Suppl 2():31-4; discussion 39-41. PubMed ID: 2180716 [TBL] [Abstract][Full Text] [Related]
19. [The use of the preparation Nimotop in neurosurgical patients]. Amcheslavskiĭ VG; Demchuk ML; Madorskiĭ SV; Toma GI; Margishvili GM; Fokin MS; Savin IA Zh Vopr Neirokhir Im N N Burdenko; 1997; (3):41-3. PubMed ID: 9424955 [No Abstract] [Full Text] [Related]
20. [Migraine prophylaxis with calcium antagonists: a haemodynamic study using transcranial Doppler ultrasound]. Arjona A; Perula de Torres LA Rev Neurol; 2004 Feb 16-29; 38(4):316-9. PubMed ID: 14997453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]